Avalon GloboCare (ALBT) EBITDA (2015 - 2026)

Avalon GloboCare has reported EBITDA for 12 years, with the latest figure at -$4.5 million in Q1 2026.

• For the quarter ending Q1 2026, EBITDA fell 80.51% year-over-year to -$4.5 million; the trailing twelve-month figure through Mar 2026 stood at -$20.3 million (down 124.83% YoY), and the FY2025 full-year result was -$18.3 million, down 131.16% from the prior year.
• EBITDA for Q1 2026 stood at -$4.5 million, down from -$2.1 million in the prior quarter.
• The five-year high for EBITDA was -$253997.0 in Q3 2025, with the low at -$13.5 million in Q2 2025.
• Historically, EBITDA has averaged -$3.5 million across 5 years, with a median of -$2.4 million in 2022.
• The largest YoY upside for EBITDA was 84.85% in 2025 against a maximum downside of 532.06% in 2025.
• Avalon GloboCare's EBITDA stood at -$2.4 million in 2022, then slumped by 300.4% to -$9.6 million in 2023, then soared by 71.46% to -$2.7 million in 2024, then advanced by 23.89% to -$2.1 million in 2025, then slumped by 115.79% to -$4.5 million in 2026.
• The last three EBITDA figures came in at -$4.5 million (Q1 2026), -$2.1 million (Q4 2025), and -$253997.0 (Q3 2025), per Business Quant data.